Skip to main content
. 2018 Jan 24;7(1):7. doi: 10.1038/s41389-017-0022-6

Fig. 2. EBAG9 silencing suppresses cancer cell migration and modulates EMT-related gene expression.

Fig. 2

a EBAG9 silencing decreases EBAG9 protein expression in LNCaP cells. The cells were transfected with siRNA targeting EBAG9 (siEBAG9 #1) or non-targeting control siRNA (siControl). b siEBAG9 #1 inhibits LNCaP cell migration. Cells transfected with indicated siRNAs were seeded on the upper chamber and migrated cells were stained after 48 h. Representative images of migrated cells are shown. Scale bar, 20 μm. Migrated cell numbers were counted in 5 microscopic fields at least. Data are shown as mean ± SD (n = 5). c Effect of EBAG9 knockdown on EMT-related gene expression in LNCaP cells. qRT-PCR analyses for VIM, SNAI1, SNAI2, and EBAG9 mRNA were performed using RNAs prepared from LNCaP cells treated with siEBAG9 #1 or siControl. Data are shown as mean ± SD (n = 3). *P < 0.05; **P < 0.01 (two-sided Student’s t-test)